Barclays’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-26,470
| Closed | -$34K | – | 5386 |
|
|
2022
Q1 | $34K | Sell |
26,470
-186,515
| -88% | -$172K | ﹤0.01% | 4266 |
|
|
2021
Q4 | $271K | Buy |
212,985
+80,031
| +60% | +$143K | ﹤0.01% | 3459 |
|
|
2021
Q3 | $290K | Sell |
132,954
-41,425
| -24% | -$113K | ﹤0.01% | 3436 |
|
|
2021
Q2 | $653K | Sell |
174,379
-29,694
| -15% | -$103K | ﹤0.01% | 2917 |
|
|
2021
Q1 | $665K | Sell |
204,073
-15,820
| -7% | -$56.7K | ﹤0.01% | 3020 |
|
|
2020
Q4 | $750K | Sell |
219,893
-37,072
| -14% | -$153K | ﹤0.01% | 2963 |
|
|
2020
Q3 | $1.05M | Buy |
256,965
+80,769
| +46% | +$307K | ﹤0.01% | 2648 |
|
|
2020
Q2 | $596K | Buy |
176,196
+71,912
| +69% | +$210K | ﹤0.01% | 3195 |
|
|
2020
Q1 | $242K | Sell |
104,284
-66,581
| -39% | -$182K | ﹤0.01% | 4140 |
|
|
2019
Q4 | $622K | Sell |
170,865
-70,846
| -29% | -$572K | ﹤0.01% | 4106 |
|
|
2019
Q3 | $2.01M | Buy |
241,711
+57,593
| +31% | +$466K | ﹤0.01% | 2863 |
|
|
2019
Q2 | $1.59M | Buy |
184,118
+73,502
| +66% | +$657K | ﹤0.01% | 3179 |
|
|
2019
Q1 | $1.18M | Buy |
110,616
+51,892
| +88% | +$556K | ﹤0.01% | 3221 |
|
|
2018
Q4 | $513K | Sell |
58,724
-99,091
| -63% | -$1.26M | ﹤0.01% | 3797 |
|
|
2018
Q3 | $2.65M | Buy |
157,815
+44,267
| +39% | +$958K | ﹤0.01% | 2543 |
|
|
2018
Q2 | $2.38M | Sell |
113,548
-965,493
| -89% | -$17.9M | ﹤0.01% | 2399 |
|
|
2018
Q1 | $17.4M | Sell |
1,079,041
-8,604
| -0.8% | -$170K | 0.01% | 917 |
|
|
2017
Q4 | $20.6M | Buy |
1,087,645
+4,512
| +0.4% | +$81.7K | 0.02% | 787 |
|
|
2017
Q3 | $15.2M | Buy |
1,083,133
+57,358
| +6% | +$519K | 0.02% | 798 |
|
|
2017
Q2 | $7.64M | Buy |
1,025,775
+16,338
| +2% | +$107K | 0.01% | 1159 |
|
|
2017
Q1 | $6.56M | Buy |
1,009,437
+7,371
| +0.7% | +$41.2K | 0.01% | 1152 |
|
|
2016
Q4 | $4.44M | Sell |
1,002,066
-9,129
| -0.9% | -$38.3K | ﹤0.01% | 1466 |
|
|
2016
Q3 | $4.72M | Sell |
1,011,195
-7,589
| -0.7% | -$45K | 0.01% | 1351 |
|
|
2016
Q2 | $6.69M | Buy |
1,018,784
+25,175
| +3% | +$178K | 0.01% | 1104 |
|
|
2016
Q1 | $5.96M | Buy |
993,609
+207
| +0% | +$1.06K | 0.01% | 1056 |
|
|
2015
Q4 | $5.96M | Sell |
993,402
-75,908
| -7% | -$434K | 0.01% | 1202 |
|
|
2015
Q3 | $5.35M | Buy |
1,069,310
+70,718
| +7% | +$491K | 0.01% | 1324 |
|
|
2015
Q2 | $5.99M | Sell |
998,592
-12,494
| -1% | -$79.3K | 0.01% | 1354 |
|
|
2015
Q1 | $6.07M | Sell |
1,011,086
-2,558
| -0.3% | -$17K | 0.01% | 1415 |
|
|
2014
Q4 | $6.08M | Sell |
1,013,644
-18,798
| -2% | -$138K | 0.01% | 1533 |
|
|
2014
Q3 | $8.26M | Sell |
1,032,442
-1,958
| -0.2% | -$15.3K | 0.01% | 1330 |
|
|
2014
Q2 | $8.28M | Buy |
1,034,400
+11,298
| +1% | +$85.7K | 0.01% | 1299 |
|
|
2014
Q1 | $7.16M | Buy |
1,023,102
+11,970
| +1% | +$101K | 0.01% | 1422 |
|
|
2013
Q4 | $8.09M | Sell |
1,011,132
-47,783
| -5% | -$427K | 0.01% | 1421 |
|
|
2013
Q3 | $8.47M | Sell |
1,058,915
-26,856
| -2% | -$217K | 0.01% | 1271 |
|
|
2013
Q2 | $8.1M | Buy |
+1,085,771
| New | +$8.33M | 0.01% | 1240 |
|
Other funds holding SPPI
ACM
E
Barclays's SPPI Position: Q2 2022 in Review
Barclays sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2022, closing a stake of 26,470 shares — an estimated $34K sold.
Barclays first reported a position in SPPI in Q2 2013 and held it in 36 quarters. The position peaked at $20.6M in Q4 2017. 86 funds tracked by Wall St. Rank hold SPPI as of Q2 2022.
- Barclays reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2022 after selling out during the quarter.
- Barclays sold 26,470 Spectrum Pharmaceuticals Inc shares in Q2 2022, an estimated $34K.
- Barclays first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 36 quarters.
- Barclays's Spectrum Pharmaceuticals Inc position peaked at $20.6M in Q4 2017.
- 86 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2022.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.